Life Molecular Imaging Overview

  • Founded
  • 2012

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 79

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Life Molecular Imaging General Information

Description

Developer of novel PET tracers designed for molecular imaging research and development services. The company through its PET tracers helps improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes as well as provide services such as research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities, thereby allowing physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine.

Contact Information

Website
www.life-mi.com
Formerly Known As
Piramal Imaging
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Diagnostic Equipment
Parent Company
Primary Office
  • Tegeler Strasse 6-7
  • 13353 Berlin
  • Germany
+49 030 000000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Life Molecular Imaging Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Life Molecular Imaging‘s full profile, request access.

Request a free trial

Life Molecular Imaging Patents

Life Molecular Imaging Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3088219-A1 Novel method of preparing an imaging compound Pending 24-Jan-2018 0000000000
US-20210038747-A1 Novel method of preparing an imaging compound Pending 24-Jan-2018 0000000000
EP-3743427-A1 Novel method of preparing an imaging compound Pending 24-Jan-2018 0000000000
EP-3743423-A1 Gamma-carboline compounds for the detection of tau aggregates Pending 24-Jan-2018 0000000000
EP-3743426-A1 Azacarboline compounds for the detection of tau aggregates Pending 24-Jan-2018 G01N33/60
To view Life Molecular Imaging’s complete patent history, request access »

Life Molecular Imaging Executive Team (4)

Name Title Board Seat Contact Info
Ludger Dinkelborg Ph.D Managing Director
Michel Jongens Managing Director
Andrew Stephens MD Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Life Molecular Imaging Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Life Molecular Imaging Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Life Molecular Imaging‘s full profile, request access.

Request a free trial